Avior Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-26
| Closed | -$226 | – | 2991 |
|
2024
Q1 | $226 | Buy |
+26
| New | +$226 | ﹤0.01% | 2824 |
|
2022
Q2 | – | Sell |
-39,779
| Closed | -$500K | – | 1150 |
|
2022
Q1 | $500K | Sell |
39,779
-7,541
| -16% | -$94.8K | 0.04% | 297 |
|
2021
Q4 | $551K | Buy |
47,320
+5,306
| +13% | +$61.8K | 0.05% | 313 |
|
2021
Q3 | $548K | Buy |
42,014
+1,995
| +5% | +$26K | 0.05% | 296 |
|
2021
Q2 | $515K | Buy |
40,019
+7,474
| +23% | +$96.2K | 0.05% | 292 |
|
2021
Q1 | $363K | Sell |
32,545
-75
| -0.2% | -$837 | 0.04% | 342 |
|
2020
Q4 | $371K | Buy |
32,620
+10,640
| +48% | +$121K | 0.05% | 320 |
|
2020
Q3 | $197K | Buy |
21,980
+1,370
| +7% | +$12.3K | 0.03% | 377 |
|
2020
Q2 | $212K | Buy |
20,610
+3,600
| +21% | +$37K | 0.03% | 374 |
|
2020
Q1 | $171K | Buy |
+17,010
| New | +$171K | 0.03% | 364 |
|